440 related articles for article (PubMed ID: 35312993)
1. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
[TBL] [Abstract][Full Text] [Related]
2. Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.
Kadriu B; Greenwald M; Henter ID; Gilbert JR; Kraus C; Park LT; Zarate CA
Int J Neuropsychopharmacol; 2021 Jan; 24(1):8-21. PubMed ID: 33252694
[TBL] [Abstract][Full Text] [Related]
3. Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.
Johnston JN; Kadriu B; Allen J; Gilbert JR; Henter ID; Zarate CA
Neuropharmacology; 2023 Mar; 226():109422. PubMed ID: 36646310
[TBL] [Abstract][Full Text] [Related]
4. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
5. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
7. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
8. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
Aleksandrova LR; Phillips AG
Trends Pharmacol Sci; 2021 Nov; 42(11):929-942. PubMed ID: 34565579
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
Aleksandrova LR; Phillips AG; Wang YT
J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
[TBL] [Abstract][Full Text] [Related]
10. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
11. The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways.
Ren L
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110910. PubMed ID: 38061484
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ketamine and its metabolites as antidepressants.
Hess EM; Riggs LM; Michaelides M; Gould TD
Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492
[TBL] [Abstract][Full Text] [Related]
13. The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
Monteggia LM; Gideons E; Kavalali ET
Biol Psychiatry; 2013 Jun; 73(12):1199-203. PubMed ID: 23062356
[TBL] [Abstract][Full Text] [Related]
14. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
15. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.
Krystal JH; Kavalali ET; Monteggia LM
Neuropsychopharmacology; 2024 Jan; 49(1):41-50. PubMed ID: 37488280
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.
Chen T; Cheng L; Ma J; Yuan J; Pi C; Xiong L; Chen J; Liu H; Tang J; Zhong Y; Zhang X; Liu Z; Zuo Y; Shen H; Wei Y; Zhao L
Pharmacol Res; 2023 Aug; 194():106837. PubMed ID: 37379962
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.
Chruścicka-Smaga B; Machaczka A; Szewczyk B; Pilc A
Pharmacol Rep; 2023 Dec; 75(6):1341-1349. PubMed ID: 37932583
[TBL] [Abstract][Full Text] [Related]
18. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
20. Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect.
Bottemanne H; Berkovitch L; Gauld C; Balcerac A; Schmidt L; Mouchabac S; Fossati P
Neurosci Biobehav Rev; 2023 Nov; 154():105410. PubMed ID: 37793581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
